Latest news
Loading news…
Orakl Oncology
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Villejuif, Ile-de-France, France Founded 2023 1-10 employees For Profit
Orakl Oncology is a precision oncology company that combines data and biology to bring new drugs to cancer patients.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 16
- IT spend
- $49K
Company Info
- Founded
- 2023
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 25
- HQ
- Villejuif, Ile-de-France, France
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 1.8
- Trend (90d)
- 1
Key People at Orakl Oncology
Co-Founder and CTO
Chief Operating Officer and Co-Founder
CEO and Founder
5
professional contacts at Orakl Oncology
Contact execs at Orakl Oncology →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Orakl Oncology
Loading news…
FAQs about Orakl Oncology
People who checked this page also checked these
Browse the full Acquirezy directory.